Lack of association between deficient mismatch repair expression and outcome in endometrial carcinomas of the endometrioid type

Gynecologic Oncology

Volumn 134, Issue 1, 2014, Pages 20-23

  Ruiz, Irune ^a   Martín Arruti, Maialen ^a,b   Lopez Lopez, Elixabet ^b   Garcia Orad, Africa ^b  

^a HOSPITAL DONOSTIA   (Spain)

^b UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Endometrioid carcinomas; Immunohistochemistry; Mismatch repair; Outcome

Indexed keywords

ANTINEOPLASTIC AGENT; MISMATCH REPAIR PROTEIN; MISMATCH REPAIR PROTEIN PMS2; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6; PROTEIN PMS6; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOMETRIAL CARCINOMA OF THE ENDOMETRIOID TYPE; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CARCINOMA; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LOG RANK TEST; LYMPH NODE DISSECTION; LYMPH VESSEL METASTASIS; MIDDLE AGED; MISMATCH REPAIR; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; TISSUE MICROARRAY; FOLLOW UP; MICROSATELLITE INSTABILITY; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; SURVIVAL;

ENDOMETRIOID CARCINOMAS; IMMUNOHISTOCHEMISTRY; MISMATCH REPAIR; OUTCOME;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOSINE TRIPHOSPHATASES; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, ENDOMETRIOID; DNA MISMATCH REPAIR; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; NEOPLASM STAGING; NUCLEAR PROTEINS; PROGNOSIS;

EID: 84903212614     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2014.04.053     Document Type: Article

References (14)

1. X. Matias-Guiu, and J. Prat Molecular pathology of endometrial carcinoma Histopathology 62 2013 111 123
2. T. Alvarez, E. Miller, L. Duska, and E. Oliva Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma? Am J Surg Pathol 36 2012 753 761
3. H.B. Salvesen, I. Haldorsen, and J. Trovic Markers for individualised therapy in endometrial carcinoma Lancet Oncol 13 2013 353 361
4. A. Yeremian, G. Moreno-Bueno, X. Dolcet, L. Catasus, M. Abal, and E. Colas et al. Endometrial carcinoma: molecular alterations involved in tumor development and progression Oncogene 2012 1 11
5. K. Banno, K. Oiri, M. Yanokura, K. Tsuni, K. Masuda, and A. Ueki et al. Biomarkers in endometrial cancer: possible clinical applications Oncol Lett 3 2012 1175 1180
6. K.Y. Terada, M. Black, L.H. Terada, J. Davis, and D.M. Shimizu Survival of endometrial cancer patients with lymphatic invasion and deficient mismatch repair expression Gynecol Oncol 129 2013 188 192
7. R. Nout, T. Bosse, C.L. Creutzberg, I.M. Jürgenliemk-Schulz, J.J. Jobsen, and L.C. Lutgens et al. Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K-AKT, Wnt/β-catenin and P53 pathway activation Gynecol Oncol 126 2012 466 473
8. H.J. An, K.I. Kim, J.Y. Kim, J.Y. Shim, H. Kang, and T.H. Kim et al. Microsatellite Instability in endometrioid type endometrial adenocarcinoma is associated with poor prognostic indicators Am J Surg Pathol 31 2007 846 853 (Pubitemid 47165137)
9. I. Zighelboim, P.J. Goodfellow, F. Gao, R.K. Gibb, M.A. Powell, and J.S. Rader et al. Microsatellite instability and epigenetic inactivation of MLH1 and outcome of patients with endometrial carcinomas of the endometrioid type J Clin Oncol 15 2007 2042 2048 (Pubitemid 46972789)
10. H.J. Mackay, S. Gallinger, M.S. Tsao, C.M. McLachlin, D. Tu, and K. Keiser et al. Prognostic value of microsatellite instability (MSI) and PTEN expression in women with endometrial cancer: results from studies of the NCIC Clinical Trials Group (NCIC CTG) Eur J Cancer 46 2010 1365 1373
11. D. Black, R.A. Soslow, D.A. Levine, C. Tornos, S.C. Chen, and A.J. Hummer et al. Clinicopathologic significance of defective DNA mismatch repair in endometrial carcinoma J Clin Oncol 24 11 2006 1745 1753 (Pubitemid 46622146)
12. D.E. Cohn, W.L. Frankel, K.E. Resnick, V.L. Zanagnolo, L.J. Copeland, and H. Hampel et al. Improved survival with an intact DNA mismatch repair system in endometrial cancer Obstet Gynecol 105 5 2006 1208 1215 (Pubitemid 44665417)
13. G.S. Nelson, A. Pink, S. Lee, G. Han, and D. Morrin et al. MMR deficiency is common in hight-grade endometrioid carcinomas and is associated with an unfavourable outcome Gynecol Oncol 131 2013 309 314
14. B.A. Clarke, and K. Cooper Identifying Lynch Syndrome patients with endometrial carcinoma: shortcomings of morphologic and clinical schemas Adv Anat Pathol 19 2012 231 238